Back to mobile site

XTL Biopharma (XTLB) Posts Breakeven Q4 Loss

April 28, 2015 7:46 AM EDT

XTL Biopharma (NASDAQ: XTLB) reported Q4 EPS of $-0.00, versus $-0.00 reported last year.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings